Todd C Brady is Director of F-star Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FSTX, which is worth approximately $0. The most recent transaction as insider was on Mar 08, 2023, when has been sold 15,004 shares (Common Stock) at a price of $7.12 per share, resulting in proceeds of $106,828. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Todd C Brady Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$106,828 $7.12 p/Share
15,004 Reduced 100.0%
0 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
-
9,235 Added 13.34%
60,016 Common Stock

Also insider at

ALDX
Aldeyra Therapeutics, Inc. Healthcare
EVOK
Evoke Pharma Inc Healthcare
TCB

Todd C Brady

Director
Lexington, MA

Track Institutional and Insider Activities on FSTX

Follow F-star Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FSTX shares.

Notify only if

Insider Trading

Get notified when an F Star Therapeutics, Inc. insider buys or sells FSTX shares.

Notify only if

News

Receive news related to F-star Therapeutics, Inc.

Track Activities on FSTX